352 related articles for article (PubMed ID: 31431131)
1. Epigallocatechin gallate (EGCG) suppresses growth and tumorigenicity in breast cancer cells by downregulation of miR-25.
Zan L; Chen Q; Zhang L; Li X
Bioengineered; 2019 Dec; 10(1):374-382. PubMed ID: 31431131
[TBL] [Abstract][Full Text] [Related]
2. Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models.
Wei R; Mao L; Xu P; Zheng X; Hackman RM; Mackenzie GG; Wang Y
Food Funct; 2018 Nov; 9(11):5682-5696. PubMed ID: 30310905
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of epigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo.
Liu L; Hou L; Gu S; Zuo X; Meng D; Luo M; Zhang X; Huang S; Zhao X
Oncol Rep; 2015 Jan; 33(1):297-303. PubMed ID: 25333353
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo.
Tran PL; Kim SA; Choi HS; Yoon JH; Ahn SG
BMC Cancer; 2010 Jun; 10():276. PubMed ID: 20537126
[TBL] [Abstract][Full Text] [Related]
5. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis.
Mittal A; Pate MS; Wylie RC; Tollefsbol TO; Katiyar SK
Int J Oncol; 2004 Mar; 24(3):703-10. PubMed ID: 14767556
[TBL] [Abstract][Full Text] [Related]
6. Lup-20(29)-en-3β,28-di-yl-nitrooxy acetate affects MCF-7 proliferation through the crosstalk between apoptosis and autophagy in mitochondria.
Yan X; Yang L; Feng G; Yu Z; Xiao M; Cai W; Xing Y; Bai S; Guo J; Wang Z; Wang T; Zhang R
Cell Death Dis; 2018 Feb; 9(2):241. PubMed ID: 29445224
[TBL] [Abstract][Full Text] [Related]
7. Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma.
Nihal M; Ahmad N; Mukhtar H; Wood GS
Int J Cancer; 2005 Apr; 114(4):513-21. PubMed ID: 15609335
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells.
Liu L; Ju Y; Wang J; Zhou R
Pathol Res Pract; 2017 Oct; 213(10):1242-1250. PubMed ID: 28964574
[TBL] [Abstract][Full Text] [Related]
9. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line.
Farabegoli F; Papi A; Bartolini G; Ostan R; Orlandi M
Phytomedicine; 2010 Apr; 17(5):356-62. PubMed ID: 20149610
[TBL] [Abstract][Full Text] [Related]
10. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of miR-126 sensitizes osteosarcoma cells to apoptosis induced by epigallocatechin-3-gallate.
Jiang L; Tao C; He A; He X
World J Surg Oncol; 2014 Dec; 12():383. PubMed ID: 25510179
[TBL] [Abstract][Full Text] [Related]
12. Green tea polyphenol EGCG suppresses osteosarcoma cell growth through upregulating miR-1.
Zhu K; Wang W
Tumour Biol; 2016 Apr; 37(4):4373-82. PubMed ID: 26499783
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin-3-gallate potentiates the effect of curcumin in inducing growth inhibition and apoptosis of resistant breast cancer cells.
Wang S; Chen R; Zhong Z; Shi Z; Chen M; Wang Y
Am J Chin Med; 2014; 42(5):1279-300. PubMed ID: 25242081
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative and apoptotic effect of epigallocatechin-3-gallate on Ishikawa cells is accompanied by sex steroid receptor downregulation.
Park SB; Bae JW; Kim JM; Lee SG; Han M
Int J Mol Med; 2012 Nov; 30(5):1211-8. PubMed ID: 22923012
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling.
Yuan CH; Horng CT; Lee CF; Chiang NN; Tsai FJ; Lu CC; Chiang JH; Hsu YM; Yang JS; Chen FA
Environ Toxicol; 2017 Mar; 32(3):845-855. PubMed ID: 27200496
[TBL] [Abstract][Full Text] [Related]
16. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
[TBL] [Abstract][Full Text] [Related]
17. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP
Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343
[TBL] [Abstract][Full Text] [Related]
18. Furanodiene, a natural product, inhibits breast cancer growth both in vitro and in vivo.
Zhong Z; Dang Y; Yuan X; Guo W; Li Y; Tan W; Cui J; Lu J; Zhang Q; Chen X; Wang Y
Cell Physiol Biochem; 2012; 30(3):778-90. PubMed ID: 22854281
[TBL] [Abstract][Full Text] [Related]
19. Honokiol nanoparticles based on epigallocatechin gallate functionalized chitin to enhance therapeutic effects against liver cancer.
Tang P; Sun Q; Yang H; Tang B; Pu H; Li H
Int J Pharm; 2018 Jul; 545(1-2):74-83. PubMed ID: 29715531
[TBL] [Abstract][Full Text] [Related]
20. Synergy of theophylline reduces necrotic effect of berberine, induces cell cycle arrest and PARP, HMGB1, Bcl-2 family mediated apoptosis in MDA-MB-231 breast cancer cells.
Hashemi-Niasari F; Rabbani-Chadegani A; Razmi M; Fallah S
Biomed Pharmacother; 2018 Oct; 106():858-867. PubMed ID: 30119256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
